376 related articles for article (PubMed ID: 9126384)
1. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
Yamabhai M; Kay BK
Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
[TBL] [Abstract][Full Text] [Related]
2. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
4. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
6. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
[TBL] [Abstract][Full Text] [Related]
7. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
Chan DC; Bedford MT; Leder P
EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
[TBL] [Abstract][Full Text] [Related]
8. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
[TBL] [Abstract][Full Text] [Related]
9. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
Pisabarro MT; Serrano L
Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
[TBL] [Abstract][Full Text] [Related]
10. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.
Sparks AB; Hoffman NG; McConnell SJ; Fowlkes DM; Kay BK
Nat Biotechnol; 1996 Jun; 14(6):741-4. PubMed ID: 9630982
[TBL] [Abstract][Full Text] [Related]
11. SH3-SPOT: an algorithm to predict preferred ligands to different members of the SH3 gene family.
Brannetti B; Via A; Cestra G; Cesareni G; Helmer-Citterich M
J Mol Biol; 2000 Apr; 298(2):313-28. PubMed ID: 10764600
[TBL] [Abstract][Full Text] [Related]
12. A novel peptide-SH3 interaction.
Mongioví AM; Romano PR; Panni S; Mendoza M; Wong WT; Musacchio A; Cesareni G; Di Fiore PP
EMBO J; 1999 Oct; 18(19):5300-9. PubMed ID: 10508163
[TBL] [Abstract][Full Text] [Related]
13. The C-terminal SH3 domain of p67phox binds its natural ligand in a reverse orientation.
Finan P; Koga H; Zvelebil MJ; Waterfield MD; Kellie S
J Mol Biol; 1996 Aug; 261(2):173-80. PubMed ID: 8757285
[TBL] [Abstract][Full Text] [Related]
14. Interaction of SH3 domain of Hck tyrosine kinase with cellular proteins containing proline-rich regions: evidence for modulation by unique domain.
Gouri BS; Swarup G
Indian J Biochem Biophys; 1997; 34(1-2):29-39. PubMed ID: 9343926
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Fyn-selective SH3 domain ligands via a combinatorial library strategy.
Li H; Lawrence DS
Chem Biol; 2005 Aug; 12(8):905-12. PubMed ID: 16125102
[TBL] [Abstract][Full Text] [Related]
16. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
17. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
[TBL] [Abstract][Full Text] [Related]
19. Acan125 binding to the SH3 domain of acanthamoeba myosin-IC.
Zot HG; Bhaskara V; Liu L
Arch Biochem Biophys; 2000 Mar; 375(1):161-4. PubMed ID: 10683262
[TBL] [Abstract][Full Text] [Related]
20. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
